Peel Hunt is acting as NOMAD and Corporate Broker to Ixico plc on its proposed acquisition of Optimal Medicine, the conditional placing of 8,852,459 Placing Shares at 30.5 pence per share (with a Broker Option of up to a further additional 327,868 shares at 30.5 pence per share), a proposed Rule 9 waiver and a proposed share restructuring (sub-division and re-designation of each Existing Ordinary Share into one Ordinary Share of 1 pence and one Deferred Share of 49 pence), as announced on 18 November, 2015.
